VIGILI de KREUTZENBERG, SAULA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.832
AS - Asia 3.612
EU - Europa 2.294
AF - Africa 1.036
SA - Sud America 846
OC - Oceania 109
Continente sconosciuto - Info sul continente non disponibili 65
Totale 18.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.325
SG - Singapore 1.257
CN - Cina 819
BR - Brasile 506
HK - Hong Kong 431
DE - Germania 247
FI - Finlandia 246
IT - Italia 228
SE - Svezia 164
GB - Regno Unito 158
VN - Vietnam 143
PL - Polonia 122
UA - Ucraina 119
FR - Francia 108
RU - Federazione Russa 96
IN - India 73
AR - Argentina 52
NL - Olanda 52
TR - Turchia 50
IE - Irlanda 48
KR - Corea 47
MX - Messico 47
IQ - Iraq 43
PY - Paraguay 43
PE - Perù 42
BJ - Benin 39
EC - Ecuador 39
ZA - Sudafrica 37
CO - Colombia 36
CW - ???statistics.table.value.countryCode.CW??? 36
AE - Emirati Arabi Uniti 35
CI - Costa d'Avorio 35
DO - Repubblica Dominicana 35
GH - Ghana 35
MD - Moldavia 35
PA - Panama 35
BE - Belgio 34
JP - Giappone 34
RO - Romania 34
AO - Angola 33
CZ - Repubblica Ceca 33
CV - Capo Verde 32
JO - Giordania 32
MY - Malesia 32
TH - Thailandia 32
BA - Bosnia-Erzegovina 31
KE - Kenya 31
MA - Marocco 31
NZ - Nuova Zelanda 31
AL - Albania 30
AT - Austria 30
ID - Indonesia 30
ZW - Zimbabwe 30
BB - Barbados 29
IL - Israele 29
ML - Mali 29
VE - Venezuela 29
YT - Mayotte 29
CA - Canada 28
GF - Guiana Francese 28
LB - Libano 28
LU - Lussemburgo 28
MR - Mauritania 28
MZ - Mozambico 28
SK - Slovacchia (Repubblica Slovacca) 28
SN - Senegal 28
CG - Congo 27
DK - Danimarca 27
DZ - Algeria 27
GT - Guatemala 27
IS - Islanda 27
LA - Repubblica Popolare Democratica del Laos 27
TN - Tunisia 27
TT - Trinidad e Tobago 27
ZM - Zambia 27
AU - Australia 26
EE - Estonia 26
ES - Italia 26
GM - Gambi 26
KG - Kirghizistan 26
NP - Nepal 26
PK - Pakistan 26
RS - Serbia 26
TZ - Tanzania 26
CR - Costa Rica 25
DJ - Gibuti 25
GA - Gabon 25
HR - Croazia 25
HU - Ungheria 25
PH - Filippine 25
PS - Palestinian Territory 25
SA - Arabia Saudita 25
UG - Uganda 25
AD - Andorra 24
AM - Armenia 24
BO - Bolivia 24
BZ - Belize 24
CY - Cipro 24
IR - Iran 24
KH - Cambogia 24
Totale 17.642
Salva come PNG Salva come JPEG
Città #
Fairfield 1.658
Woodbridge 992
Ashburn 890
Houston 780
Singapore 765
Chandler 668
Ann Arbor 642
Seattle 585
Cambridge 561
Wilmington 560
Jacksonville 430
Hong Kong 411
Beijing 223
Boardman 196
Princeton 188
Santa Clara 169
San Diego 120
Roxbury 118
Helsinki 91
Guangzhou 82
Nanjing 82
Des Moines 81
Medford 75
Los Angeles 73
Bytom 71
Chicago 69
Padova 58
Munich 55
São Paulo 53
Hefei 51
Ho Chi Minh City 43
Dublin 39
Shanghai 38
Cotonou 36
Panama City 35
Abidjan 34
Buffalo 33
New York 33
Amman 32
Turku 32
Accra 31
Dearborn 30
Harare 29
Nanchang 29
Dakar 28
Hanoi 28
Seoul 28
Willemstad 28
Dong Ket 27
Lusaka 27
Bamako 26
Nairobi 26
Praia 26
Bishkek 25
London 25
Shenyang 25
Bridgetown 24
Nouakchott 24
Vienna 24
Andorra la Vella 23
Libreville 23
Lima 23
Luanda 23
Maputo 23
Salt Lake City 23
Vientiane 23
Baghdad 22
Baku 22
Kampala 22
Podgorica 22
Hebei 21
Phnom Penh 21
Reykjavik 21
Tashkent 21
Asunción 20
Conakry 20
Dar es Salaam 20
Djibouti 20
Dushanbe 20
Kigali 20
Montevideo 20
Noumea 20
Ogden 20
Addis Ababa 19
Antananarivo 19
Auckland 19
Brooklyn 19
Chisinau 19
Niamey 19
Tallinn 19
Warsaw 19
Yerevan 19
Cayenne 18
Council Bluffs 18
Guatemala City 18
Jiaxing 18
Kingstown 18
Castries 17
Chennai 17
Dallas 17
Totale 12.487
Salva come PNG Salva come JPEG
Nome #
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 260
NETosis delays diabetic wound healing in mice and humans 258
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 238
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 226
NETosis is induced by high glucose and associated with type 2 diabetes. 222
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 221
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 213
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 212
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 202
Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes 196
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 194
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 194
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 193
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 189
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 189
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 189
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 187
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 186
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 182
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 181
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 181
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 180
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 176
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history 168
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 168
No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. 167
Impaired hemodynamic response to meal intake in insulin-resistant subjects: an impedance cardiography approach 167
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 166
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 164
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 163
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 162
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 162
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 161
At the crossroads of longevity and metabolism: The metabolic syndrome and lifespan determinant pathways 160
Mechanisms of acute and chronic hypoglycemic action of gliclazide 159
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 158
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 157
Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. 156
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 156
NAD+-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. 155
Dose-response curves of effects of insulin on leucine kinetics in humans. 153
Endothelial dysfunction in type 2 diabetes mellitus. 152
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. 152
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 151
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 151
Monocyte-macrophage polarization balance in pre-diabetic individuals. 148
Development of the metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects. 147
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 145
Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. 145
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 144
Hemodynamics assessed via approximate entropy analysis of impedance cardiography time series: effect of metabolic syndrome 143
Glycaemic fall after a glucose load. A population-based study 143
Effects of androgens on endothelial progenitor cells in vitro and in vivo 142
Is the metabolic syndrome a cardiovascular risk factor beyond its specific components? 141
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes. 137
Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid? 135
Diabetic cardiomyopathy: A metabolic perspective 134
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 133
Non esterified fatty acids and endothelial dysfunction 132
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 131
The limited clinical value of a specific diabetic cardiomyopathy. 131
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications 131
Modification of glucose tolerance and insulin-mediated glucose and non-esterified fatty acids utilization in morbid obese patients after a surgically induced massive weight loss. 130
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 130
Glucose tolerance is negatively associated with circulating progenitor cell levels. 129
Insulin signaling and life span 128
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 126
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study 126
Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients 126
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes 125
Glucose and ketone body turnover in carnitine-palmitoyl-transferase deficiency. 125
Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy. 125
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 124
The metabolic syndrome influences the response to incretin-based therapies. 124
Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. 124
Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma 123
Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection. 123
Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. 123
Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance 122
One-year caloric restriction and 12-week exercise training intervention in obese adults with type 2 diabetes: emphasis on metabolic control and resting metabolic rate 122
The endothelium abridges insulin resistance to premature aging. 121
Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients. 120
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 120
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 119
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. 119
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 119
Circulating progenitor cells are reduced in patients with severe lung disease 119
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 118
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients. 117
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 117
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 117
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 116
Mechanisms of endothelial dysfunction in obesity 114
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 114
Sirtuin 1 stabilization by HuR represses TNF-α and glucose induced E-Selectin release and endothelial cell adhesiveness in vitro. Relevance to human metabolic syndrome. 114
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 111
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 110
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 110
Oral 17beta-estradiol and sequential progesterone in menopause: effects on insulin-like growth factors and their binding proteins. 109
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy] 107
Totale 15.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.541
article - articoli 55.791
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 523
Totale 114.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.524 0 0 0 0 76 155 43 200 257 429 218 146
2021/20221.746 49 188 198 128 85 117 74 209 100 41 182 375
2022/20231.320 268 137 14 179 193 191 5 98 166 9 46 14
2023/2024662 29 95 59 44 57 36 48 21 36 106 60 71
2024/20252.823 8 226 145 128 370 74 119 212 231 105 503 702
2025/20265.512 483 1.032 1.664 2.089 244 0 0 0 0 0 0 0
Totale 18.897